Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4422

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Chemical structure of atorvastatin calcium showing its detailed molecular layout, including multiple aromatic rings, hydroxyl groups, and calcium ions with associated waters of hydration.*

FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

A cumulative incidence graph showing percentage over time in years. It compares two lines representing Atorvastatin and Placebo groups. The Atorvastatin line is solid, demonstrating a lower cumulative incidence percentage compared to the dashed Placebo line. The graph includes a hazard ratio (HR) of 0.64 with a confidence interval and a p-value of 0.0005.*

FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

A line graph depicting cumulative hazard percentage over time in years for Atorvastatin and placebo groups. The x-axis shows time to first primary endpoint from 0 to 5 years of follow-up. The y-axis represents cumulative hazard from 0 to 15%. Atorvastatin is shown with a solid line and placebo with a dashed line, with lower cumulative hazard in the Atorvastatin group. The graph includes a hazard ratio (HR) of 0.63 with confidence interval 0.48-0.83 and p-value 0.001.*

FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

A Kaplan-Meier curve comparing the percentage of subjects experiencing a first major cardiovascular event over time for two Atorvastatin dosages: 10 mg and 80 mg. The X-axis shows time in years (0 to 5), and the Y-axis shows the percentage of subjects experiencing the event (0 to 0.2). The chart includes a hazard ratio (HR) of 0.78 (95% CI 0.69-0.89) with a p-value of 0.0002, indicating a statistical comparison between the two dosage groups.*

FDA Label Image

Remedy_label (Remedy Label)

Atorvastatin Calcium 10 mg film-coated tablets, pack of 100, labeled for prescription use only. The label shows the product as repackaged by RemedyRepack Inc., Indiana, PA. Additional details include storage instructions and manufacturer information (LifeStar, Mahwah, NJ). Tablets are described as oval white tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.